SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
--------
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 19, 2003
Commission File Number: 1-18592
Merit Medical Systems, Inc.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Utah 87-0447695
------------------------------- ---------------
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
1600 W. Merit Parkway
South Jordan, Utah 84095-2415
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code:
-----------------------------------------
(801) 253-1600
(Former name, former address, and formal fiscal year, if changed
since last report)
----------------------------------------------------------
N/A
ITEM 9. REGULATION FD DISCLOSURE
MERIT MEDICAL CHAIRMAN AND CEO SAYS SALES ARE ROBUST
FOR JANUARY AND FIRST HALF OF FEBRUARY
SOUTH JORDAN, UTAH--Fred Lampropoulos, Chairman and CEO, Merit Medical
Systems, Inc. (NASDAQ:NMS: MMSI) said in a conference call yesterday that sales
for the month of January and the first two weeks of February were "robust." The
purpose of the conference call was to report financial results for fourth
quarter and the year ended December 31, 2002.
Mr. Lampropoulos reported, "The business exceeded our [internal]
forecast for January, and sales are at record levels [for daily sales] for the
first two weeks in February." He further added that he is quite satisfied with
the performance of the Company for 2002 and that he looks forward to a "good
year" in 2003.
In addition, Mr. Lampropoulos indicated there is upside potential to
the financial guidance for 2003 that was provided in yesterday's news release.
Growth for this year could come from recently secured contracts with group
purchasing organizations. Other areas for potential growth are from sales of
Merit's new safety needle, its recently introduced drainage catheters, and a new
safety procedural kit for vessel access.
Today, Mr. Lampropoulos said, "We try to provide the best guidance we
possibly can and not disappoint. The guidance we gave is conservative and
provides our best estimate as to how our business will go through the year. We
like to present a number that we can meet or exceed."
ABOUT MERIT
Founded in 1987, Merit Medical Systems is a publicly-traded company
engaged in the development, manufacture, and distribution of proprietary
disposable medical products used in interventional and diagnostic procedures,
particularly in cardiology and radiology. The Company serves client hospitals
worldwide with a domestic and international sales force totaling approximately
70 individuals. Merit Medical employs approximately 1,070 individuals worldwide,
with manufacturing facilities in South Jordan and Salt Lake City, Utah; Santa
Clara, California; Angleton, Texas; and Galway, Ireland. For more information
about Merit Medical, visit www.merit.com.
Statements contained in this release which are not purely historical
are forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 and are subject to risks and uncertainties such as
those described in the Company's Annual Report on Form 10-K for the year ended
December 31, 2001. Such risks and uncertainties include introduction of products
in a timely fashion, market acceptance of new products, cost increases,
fluctuations in and obsolescence of inventory, price and product competition,
availability of labor and materials, development of new products and techniques
that render the Company's products obsolete, delays in obtaining regulatory
approvals, potential product recalls, foreign currency fluctuations, changes in
health care markets related to health care reform initiatives, litigation, and
other factors referred to in the Company's Form 10-K and other reports filed
with the Securities and Exchange Commission. All subsequent forward-looking
statements attributable to the Company or persons acting on its behalf are
expressly qualified in their entirety by these cautionary statements. Actual
results may differ materially from anticipated results. Financial estimates are
subject to change and are not intended to be relied upon as predictions of
future operating results.
2
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: February 20, 2003 MERIT MEDICAL SYSTEMS, INC.
By /s/ Kent W. Stanger
------------------------------------------
Kent W. Stanger
(Chief Financial Officer
Principal Financial and Accounting Officer)
3